N. Gašperšič
Ljubljana University Medical Centre
19 Papers
53 Citations
N. Gašperšič is an academic researcher from Ljubljana University Medical Centre. The author has contributed to research in topics: Antiphospholipid syndrome & Lupus anticoagulant. The author has an hindex of 8, co-authored 19 publications.
Chat about Author
Papers
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements
Polona Žigon,Anuška Podovšovnik,A. Ambrožič,Matija Tomšič,Matija Tomšič,Alojzija Hočevar,N. Gašperšič,Žiga Rotar,Sonja Praprotnik,Snežna Sodin Šemrl,Snežna Sodin Šemrl,Saša Čučnik,Saša Čučnik +12 more
TL;DR: The aims of this cross-sectional, retrospective study of consecutive autoimmune patients’ samples were to evaluate the association of non-criteria antiphospholipid antibodies (aPL) with thrombosis and obstetric events, to calculate the risk score for adverse events and to assess the specific contribution of single aPL positivity in SN-APS.
36
Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-β2-glycoprotein I and anti-annexin A5 antibodies
TL;DR: The results point to the competition between FANXA5 and complexes of beta2G PI-abeta2GPI for the same binding sites and therefore support the hypothesis of the disruption of the ANXA 5 protective shield on procoagulant phospholipid surface.
24
Antibodies against annexin A5: detection pitfalls and clinical associations.
TL;DR: This review has endeavoured to summarise essential information about the detection of anti-annexin V antibodies (aANXA5) and their clinical relevance, and brought together some relevant published data concerning the structure, physiological role and therapeutic potential of ANxA5.
21
Anti-annexin V antibodies in patients with cerebrovascular disease.
TL;DR: Two patients with CVD who had evidently raised levels of IgG aANXV are reported on, whereas all the other tested antiphospholipid antibodies (aPL) were negative.
17